354 related articles for article (PubMed ID: 19694500)
1. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Rychli K; Huber K; Wojta J
Expert Opin Ther Targets; 2009 Nov; 13(11):1295-302. PubMed ID: 19694500
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
3. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
[TBL] [Abstract][Full Text] [Related]
4. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
Filleur S; Volz K; Nelius T; Mirochnik Y; Huang H; Zaichuk TA; Aymerich MS; Becerra SP; Yap R; Veliceasa D; Shroff EH; Volpert OV
Cancer Res; 2005 Jun; 65(12):5144-52. PubMed ID: 15958558
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.
Barnstable CJ; Tombran-Tink J
Prog Retin Eye Res; 2004 Sep; 23(5):561-77. PubMed ID: 15302351
[TBL] [Abstract][Full Text] [Related]
6. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
8. Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor.
Penn JS; McCollum GW; Barnett JM; Werdich XQ; Koepke KA; Rajaratnam VS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):405-14. PubMed ID: 16384991
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of pigment-epithelium-derived factor in rat cochlea.
Gleich O; Piña AL
Cell Tissue Res; 2008 Jun; 332(3):565-71. PubMed ID: 18418629
[TBL] [Abstract][Full Text] [Related]
10. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of functional recombinant human pigment epithelium-derived factor (PEDF) secreted by the yeast Pichia pastoris.
Sánchez-Sánchez F; Aroca-Aguilar JD; Segura I; Ramírez-Castillejo C; Riese HH; Coca-Prados M; Escribano J
J Biotechnol; 2008 Mar; 134(1-2):193-201. PubMed ID: 18282627
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
[TBL] [Abstract][Full Text] [Related]
13. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic.
Dass CR; Choong PF
Pharmazie; 2008 Jan; 63(1):4-6. PubMed ID: 18271294
[TBL] [Abstract][Full Text] [Related]
15. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
Jinnouchi Y; Yamagishi S; Matsui T; Takenaka K; Yoshida Y; Nakamura K; Ueda S; Imaizumi T
Brain Res; 2007 Sep; 1167():92-100. PubMed ID: 17692294
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PEDF expression by PARP inhibition contributes to the decrease in hyperglycemia-induced apoptosis in HUVECs.
Chen H; Jia W; Xu X; Fan Y; Zhu D; Wu H; Xie Z; Zheng Z
Biochem Biophys Res Commun; 2008 May; 369(2):718-24. PubMed ID: 18312852
[TBL] [Abstract][Full Text] [Related]
17. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor expression in the developing mouse eye.
Behling KC; Surace EM; Bennett J
Mol Vis; 2002 Nov; 8():449-54. PubMed ID: 12447163
[TBL] [Abstract][Full Text] [Related]
19. [Pigment epithelium-derived factor and its application in retinal angiogenic diseases].
Liu H; Su GF
Zhonghua Yan Ke Za Zhi; 2007 Nov; 43(11):1043-7. PubMed ID: 18307952
[TBL] [Abstract][Full Text] [Related]
20. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
